Abstract:The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a pandemic has been validated as an extreme clinical calamity and has affected several socio-economic activities globally. Proven transmission of this virus occurs through airborne droplets from an infected person. The recent upsurge in the number of infected individuals has already exceeded the number of intensive care beds available to patients. These extraordinary circumstances have elicited the need for the development of diagnostic tools for the detection of the virus and, hence, prevent the spread of the disease. Early diagnosis and effective immediate treatment can reduce and prevent an increase in the number of cases. Conventional methods of detection such as quantitative real-time polymerase chain reaction and chest computed tomography scans have been used extensively for diagnostic purposes. However, these present several challenges, including prolonged assay requirements, labor-intensive testing, low sensitivity, and unavailability of these resources in remote locations. Such challenges urgently require fast, sensitive, and accurate diagnostic techniques for the timely detection and treatment of coronavirus disease 2019 (COVID-19) infections. Point-of-care biosensors that include paper- and chip-based diagnostic systems are rapid, cost-effective, and user friendly. In this article nanotechnology-based potential biosensors for SARS-CoV-2 diagnosis are discussed with particular emphasis on a lateral flow assay, a surface-enhanced Raman scattering-based biosensor, a localized surface plasmon resonance-based biosensor, Förster resonance energy transfer, an electrochemical biosensor, and artificial intelligence-based biosensors. Several biomolecules, such as nucleic acids, antibodies/enzymes, or aptamers, can serve as potential detection molecules on an appropriate platform, such as graphene oxide, nanoparticles, or quantum dots. An effective biosensor can be developed by using appropriate combinations of nanomaterials and technologies.

Impact of nanotechnology on conventional and artificial intelligence-based biosensing strategies for the detection of viruses

Trends in nanomaterial-based biosensors for viral detection

Nanomaterials for virus sensing and tracking

Applications of Nanotechnology in Virus Detection, Tracking, and Infection Mechanisms

Recent Developments in Nanotechnology-Based Biosensors for the Diagnosis of Coronavirus

Emerging nanophotonic biosensor technologies for virus detection

Nanobiosensor-based diagnostic tools in viral infections: Special emphasis on Covid-19

Nanoscale virus biosensors: state of the art

Application of nanotechnology in biosensors for enhancing pathogen detection.

Nanomaterials Revolutionize Biosensing: 0D-3D Designs for Ultrasensitive Detection of Microorganisms and Viruses.

Advances in miniaturized nanosensing platforms for analysis of pathogenic bacteria and viruses

Nanomaterial Revolutionizes Biosensing: 0D-3D Designs for Ultrasensitive Detection of Microorganisms and Viruses

Nanotechnology-Assisted Biosensors for the Detection of Viral Nucleic Acids: An Overview

Nanomaterials and Nanotechnology-Associated Innovations against Viral Infections with a Focus on Coronaviruses

Nanotechnology-Based Biosensors for Biomedical Applications

Nanotechnology-Based Approaches for the Detection of SARS-CoV-2

Nanotechnology-Based Modern Biosensors for the Detection of SARS-CoV-2 Virus

Nanomaterials and Biosensing Technology for the SARS-CoV-2 Detection

The importance, benefits, and future of nanobiosensors for infectious diseases

Nanomaterials and metal-organic frameworks for biosensing applications of mutations of the emerging viruses

Recent Advances in DNA Nanotechnology-Enabled Biosensors for Virus Detection